5-[3-amino-4-[(4-methylphenyl)methylideneamino]phenyl]-2-(ethylideneamino)aniline
C22H22N4 — CID 20783051
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[3-amino-4-[(4-methylphenyl)methylideneamino]phenyl]-2-(ethylideneamino)aniline
5-[3-amino-4-[(4-methylphenyl)methylideneamino]phenyl]-2-(ethylideneamino)aniline (PubChem CID 20783051) has the molecular formula C22H22N4 and a molecular weight of 342.45 g/mol. Its IUPAC name is 5-[3-amino-4-[(4-methylphenyl)methylideneamino]phenyl]-2-(ethylideneamino)aniline.
Molecular Properties
| Compound Name | 5-[3-amino-4-[(4-methylphenyl)methylideneamino]phenyl]-2-(ethylideneamino)aniline |
|---|---|
| PubChem CID | 20783051 |
| Molecular Formula | C22H22N4 |
| Molecular Weight | 342.45 g/mol |
| Exact Mass | 342.18 |
| IUPAC Name | 5-[3-amino-4-[(4-methylphenyl)methylideneamino]phenyl]-2-(ethylideneamino)aniline |
| SMILES | C/C=N/c1ccc(-c2ccc(/N=C/c3ccc(C)cc3)c(N)c2)cc1N |
| InChI | InChI=1S/C22H22N4/c1-3-25-21-10-8-17(12-19(21)23)18-9-11-22(20(24)13-18)26-14-16-6-4-15(2)5-7-16/h3-14H,23-24H2,1-2H3/b25-3+,26-14+ |
| InChIKey | LZMMNNNMJLEGAY-ZFCFXVHXSA-N |
| XLogP | 5.30 |
| TPSA | 76.76 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 342.45 |
| LogP ≤ 5 | 5.30 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 20783051 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.